In adult patients with early septic shock diagnosed within 4 hours, does a capillary refill time (CRT)‑guided resuscitation strategy improve outcomes compared with usual lactate‑guided care?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Capillary Refill Time-Guided Resuscitation in Early Septic Shock: ANDROMEDA-SHOCK-2 Trial

A personalized hemodynamic resuscitation protocol targeting capillary refill time (CRT) is superior to usual lactate-guided care in adult patients with early septic shock, primarily by reducing the duration of vital organ support. 1

Key Trial Results

The ANDROMEDA-SHOCK-2 trial enrolled 1,467 patients across 86 centers in 19 countries and demonstrated that CRT-targeted resuscitation achieved a win ratio of 1.16 (95% CI, 1.02-1.33; P = .04) for the hierarchical composite outcome of mortality, duration of vital support, and hospital length of stay. 1 The benefit was driven predominantly by a 5.3% absolute reduction in duration of vital support (26.4% vs 21.1% wins), with smaller contributions from mortality (19.1% vs 17.8% wins) and hospital stay (3.4% vs 3.2% wins). 1

The CRT-Targeted Protocol Algorithm

The intervention group measured CRT hourly for 6 hours, and when abnormal (>3 seconds), patients entered a stepwise hemodynamic phenotyping algorithm: 2, 1

Step 1: Pulse Pressure Assessment

  • If pulse pressure <40 mmHg: Proceed to fluid responsiveness testing and administer fluids only if responsive. 2
  • If pulse pressure ≥40 mmHg: Titrate norepinephrine to maintain diastolic arterial pressure >50 mmHg. 2

Step 2: Echocardiographic Evaluation

  • Perform bedside critical care echocardiography to identify cardiac dysfunction (reduced ejection fraction, right ventricular dysfunction, or valvular abnormalities) and guide subsequent management. 2

Step 3: Vasopressor and Inodilator Optimization

  • Conduct vasopressor and inodilator tests to further optimize peripheral perfusion if CRT remains abnormal after previous steps. 2

Comparison to Lactate-Guided Resuscitation

The original ANDROMEDA-SHOCK trial (2019) compared CRT-targeted versus lactate-targeted resuscitation in 424 patients and found a non-significant trend toward lower 28-day mortality (34.9% vs 43.4%; HR 0.75,95% CI 0.55-1.02; P = .06) and significantly less organ dysfunction at 72 hours (mean SOFA score 5.6 vs 6.6; mean difference -1.00, P = .045). 3 The ANDROMEDA-SHOCK-2 trial built upon this by incorporating hemodynamic phenotyping and demonstrated clear superiority for the composite outcome. 1

Mechanistic Rationale for CRT Superiority

CRT provides real-time assessment of peripheral perfusion that may prevent over-resuscitation. 4 Lactate elevation in sepsis arises from multiple non-hypoxic mechanisms—including β-adrenergic stimulation, hepatic dysfunction, and accelerated aerobic glycolysis—making it a non-specific indicator of tissue hypoperfusion. 5 Approximately 23% of septic patients exhibit "cryptic shock" (lactate ≥2 mmol/L despite central venous oxygen saturation >70%), reflecting impaired cellular oxygen utilization rather than inadequate oxygen delivery. 5

CRT normalization indicates successful reperfusion almost immediately, allowing clinicians to stop fluid administration before overload occurs, whereas lactate clearance lags behind hemodynamic improvements by hours. 4 This temporal advantage likely explains the reduced duration of vital support in ANDROMEDA-SHOCK-2. 1

Integration with Current Guidelines

The Surviving Sepsis Campaign recommends targeting either lactate normalization or lactate clearance >20% every 2 hours during early septic shock resuscitation, alongside MAP ≥65 mmHg and urine output ≥0.5 mL/kg/h. 6, 5 The ANDROMEDA-SHOCK-2 results suggest that CRT-targeted resuscitation with hemodynamic phenotyping should be considered as an alternative or complementary strategy to lactate-guided care, particularly when bedside echocardiography is available. 1

Practical Implementation

Measure CRT by applying firm pressure to the distal phalanx of the index finger for 10 seconds, then releasing and timing the return of normal color; normal is ≤2 seconds, and >3 seconds is abnormal. 7 In the intervention protocol, CRT is assessed hourly for the first 6 hours after septic shock diagnosis. 2, 1

Key clinical perfusion markers to assess alongside CRT include: mental status (alert vs confused), extremity temperature (warm vs cold), urine output (target ≥0.5 mL/kg/h), and capillary refill time itself (target ≤2 seconds). 8, 7

Critical Caveats

Do not abandon lactate measurement entirely—initial lactate ≥4 mmol/L identifies patients with 46.1% mortality who require immediate protocolized resuscitation, and serial lactate measurements remain valuable for assessing metabolic response. 8, 7 The ANDROMEDA-SHOCK-2 protocol used CRT as the primary target but did not prohibit lactate monitoring. 1

CRT assessment requires training and standardization to minimize inter-observer variability, and ambient temperature can affect measurements (cold environments prolong CRT independent of perfusion status). 3

The hemodynamic phenotyping approach requires bedside echocardiography, which may not be universally available in all centers; however, the pulse pressure and diastolic pressure assessments can be performed with standard arterial line monitoring. 2

Clinical Bottom Line

For adult patients with early septic shock (diagnosed within 4 hours), implement a CRT-targeted resuscitation protocol with hemodynamic phenotyping rather than relying solely on lactate-guided care. 1 This approach reduces the duration of vasopressor, mechanical ventilation, and renal replacement therapy without increasing mortality, representing a more physiologically sound and resource-efficient strategy. 1 The protocol is particularly advantageous when bedside echocardiography is available to guide fluid, vasopressor, and inotrope decisions based on individual hemodynamic phenotypes. 2, 1

Related Questions

What were the design, interventions, and primary outcomes of the ANDROMEDA‑SHOCK‑2 trial comparing capillary refill time‑guided resuscitation versus lactate‑guided standard care in adult patients with early septic shock?
What are the findings of the Andromeda Shock-2 trial on early goal-directed therapy for shock?
What are the findings from the Andromeda-Shock II trial regarding the management of septic shock?
What is the protocol used in the ANDROMEDA-SHOCK-2 study for septic shock resuscitation?
What is the management protocol for septic shock in the ANDROMEDA-SHOCK-2 study?
What is the first‑line management for an adult patient diagnosed with coronary artery disease?
How should new‑onset hypertension be evaluated and treated in a patient with inflammatory bowel disease, especially if they are receiving systemic glucocorticoids?
What cardiac rehabilitation program should be initiated after percutaneous coronary intervention (angioplasty)?
What is the incidence of isolated chest trauma that leads to tension pneumothorax requiring whole‑blood transfusion?
What is the recommended evaluation and treatment plan for an adult with alcohol use disorder, including withdrawal management, medication selection based on hepatic and renal function, and psychosocial interventions?
What is the safest evidence‑based incretin‑based therapy for an obese adult with type 2 diabetes mellitus and uncontrolled glycated hemoglobin after a recent ST‑segment‑elevation myocardial infarction?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.